146 related articles for article (PubMed ID: 9589818)
41. Salmeterol compared with slow-release terbutaline in nocturnal asthma. A multicenter, randomized, double-blind, double-dummy, sequential clinical trial. French Multicenter Study Group.
Brambilla C; Chastang C; Georges D; Bertin L
Allergy; 1994 Jul; 49(6):421-6. PubMed ID: 7915501
[TBL] [Abstract][Full Text] [Related]
42. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients.
Grove A; Lipworth BJ
Lancet; 1995 Jul; 346(8969):201-6. PubMed ID: 7616798
[TBL] [Abstract][Full Text] [Related]
43. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma.
Shapiro G; Lumry W; Wolfe J; Given J; White MV; Woodring A; Baitinger L; House K; Prillaman B; Shah T
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):527-34. PubMed ID: 10673196
[TBL] [Abstract][Full Text] [Related]
44. Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies.
Faurschou P; Engel AM; Haanaes OC
Allergy; 1994 Dec; 49(10):827-32. PubMed ID: 7709991
[TBL] [Abstract][Full Text] [Related]
45. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.
Martin RJ; Kraft M; Beaucher WN; Kiechel F; Sublett JL; LaVallee N; Shilstone J
Ann Allergy Asthma Immunol; 1999 Aug; 83(2):121-6. PubMed ID: 10480584
[TBL] [Abstract][Full Text] [Related]
46. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
47. Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group.
Paggiaro PL; Giannini D; Di Franco A; Testi R
Eur Respir J; 1996 Aug; 9(8):1689-95. PubMed ID: 8866596
[TBL] [Abstract][Full Text] [Related]
48. Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma.
Weiler JM; Nathan RA; Rupp NT; Kalberg CJ; Emmett A; Dorinsky PM
Ann Allergy Asthma Immunol; 2005 Jan; 94(1):65-72. PubMed ID: 15702819
[TBL] [Abstract][Full Text] [Related]
49. A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects.
Gongora HC; Wisniewski AF; Tattersfield AE
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):626-9. PubMed ID: 1679981
[TBL] [Abstract][Full Text] [Related]
50. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
Britton MG; Earnshaw JS; Palmer JB
Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
[TBL] [Abstract][Full Text] [Related]
51. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
[TBL] [Abstract][Full Text] [Related]
52. A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma.
Nathan RA; Pinnas JL; Schwartz HJ; Grossman J; Yancey SW; Emmett AH; Rickard KA
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):521-9. PubMed ID: 10400478
[TBL] [Abstract][Full Text] [Related]
53. Randomized comparison of strategies for reducing treatment in mild persistent asthma.
; Peters SP; Anthonisen N; Castro M; Holbrook JT; Irvin CG; Smith LJ; Wise RA
N Engl J Med; 2007 May; 356(20):2027-39. PubMed ID: 17507702
[TBL] [Abstract][Full Text] [Related]
54. Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids.
Boulet LP; Cartier A; Milot J; Côté J; Malo JL; Laviolette M
Eur Respir J; 1998 May; 11(5):1091-7. PubMed ID: 9648961
[TBL] [Abstract][Full Text] [Related]
55. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases.
Murray JJ; Church NL; Anderson WH; Bernstein DI; Wenzel SE; Emmett A; Rickard KA
Allergy Asthma Proc; 1999; 20(3):173-80. PubMed ID: 10389550
[TBL] [Abstract][Full Text] [Related]
56. Pilgrim's progress: the effect of salmeterol in older children with chronic severe asthma.
Langton Hewer S; Hobbs J; French D; Lenney W
Respir Med; 1995 Jul; 89(6):435-40. PubMed ID: 7644775
[TBL] [Abstract][Full Text] [Related]
57. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial.
Lazarus SC; Boushey HA; Fahy JV; Chinchilli VM; Lemanske RF; Sorkness CA; Kraft M; Fish JE; Peters SP; Craig T; Drazen JM; Ford JG; Israel E; Martin RJ; Mauger EA; Nachman SA; Spahn JD; Szefler SJ;
JAMA; 2001 May 23-30; 285(20):2583-93. PubMed ID: 11368732
[TBL] [Abstract][Full Text] [Related]
58. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
59. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
Lee DK; Jackson CM; Currie GP; Cockburn WJ; Lipworth BJ
Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
[TBL] [Abstract][Full Text] [Related]
60. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
